International Assets Investment Management LLC Acquires 846,884 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

International Assets Investment Management LLC increased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 1,985.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 889,546 shares of the pharmacy operator's stock after purchasing an additional 846,884 shares during the quarter. International Assets Investment Management LLC owned approximately 0.10% of Walgreens Boots Alliance worth $23,226,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the business. Dark Forest Capital Management LP lifted its position in shares of Walgreens Boots Alliance by 6.5% in the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator's stock worth $654,000 after purchasing an additional 1,804 shares during the period. Deutsche Bank AG lifted its holdings in Walgreens Boots Alliance by 36.2% in the third quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator's stock worth $48,269,000 after buying an additional 576,534 shares during the period. Van ECK Associates Corp boosted its position in Walgreens Boots Alliance by 28.2% during the 3rd quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator's stock valued at $2,873,000 after acquiring an additional 28,400 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Walgreens Boots Alliance by 3.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator's stock worth $32,130,000 after acquiring an additional 47,071 shares during the period. Finally, Vanguard Group Inc. raised its position in shares of Walgreens Boots Alliance by 14.5% in the 3rd quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator's stock worth $1,927,656,000 after acquiring an additional 10,962,030 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Up 0.3 %

WBA traded up $0.06 during trading on Thursday, hitting $18.08. 13,644,421 shares of the company's stock traded hands, compared to its average volume of 14,609,577. Walgreens Boots Alliance, Inc. has a 12-month low of $17.76 and a 12-month high of $36.58. The company's 50 day simple moving average is $21.10 and its two-hundred day simple moving average is $22.11. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $15.60 billion, a price-to-earnings ratio of -2.57, a PEG ratio of 1.19 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the company earned $1.16 EPS. Analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

WBA has been the topic of several research reports. UBS Group dropped their price target on Walgreens Boots Alliance from $25.00 to $22.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 3rd. Truist Financial reaffirmed a "hold" rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Barclays began coverage on shares of Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an "underweight" rating and a $21.00 price target for the company. TD Cowen dropped their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a "buy" rating on the stock in a research note on Wednesday, April 3rd. Finally, SVB Leerink decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "market perform" rating for the company in a research note on Monday, March 18th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of "Hold" and a consensus price target of $24.36.

Insider Activity

In other news, Director Valerie B. Jarrett purchased 4,456 shares of the stock in a transaction dated Monday, January 29th. The shares were purchased at an average cost of $22.44 per share, with a total value of $99,992.64. Following the acquisition, the director now directly owns 4,456 shares of the company's stock, valued at $99,992.64. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the company's stock in a transaction that occurred on Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The shares were acquired at an average cost of $22.44 per share, with a total value of $99,992.64. Following the completion of the acquisition, the director now owns 4,456 shares of the company's stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.